Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

Figure 1

Distribution of acute phase reactant levels at baseline. Distribution of ESR and CRP levels at baseline (A) among the 9,135 patients who had a visit with active RA (CDAI >2.8), and (B) among the 4,031 biologic-naïve patients who had a visit with active RA (CDAI >2.8). CDAI, Clinical Disease Activity Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; RA, rheumatoid arthritis.

Back to article page